Safety and Efficacy of Flow Diverter Therapy for Unruptured Intracranial Aneurysm Comparing to Traditional Endovascular Strategy: A Multi-center, Randomized, Open-label Trial.

Yonsei University Health System, Severance Hospital0 个研究点目标入组 160 人开始时间: 待定最近更新: 2024年6月24日

适应症

试验速览

暂无简介。

•1) Treatment-related complications: during or after treatment hemorrhagic embolism and hemorrhagic complications that occurred within 30 days.
•2) Severe hemorrhagic(Thrombolysis in Myocardial Infarction bleeding criteria)
•3) Delayed cerebral hemorrhage: spontaneous intravenous bleeding that occurred within 12 months of treatment
•4) Delayed cerebral infarction: cerebral infarction caused by hematosis within 12 months of treatment.
•5) Neurological conditions (transfer rate and mortality rate): modified after 1 and 12 months of treatment
•Rankin scale score

•1) Adult women and men over 19 to 75 years of age
•2) A person who needs treatment due to the initial or recurrence of a cerebral aneurysm with a maximum diameter of 7 mm or more.
•3) In the case of recurrence and treatment, a person with Aneurysm Occlusion Grading System Grade 2 or higher.
•? Recurrence : Aneurysm Occlusion Grading System
•? The results of Grade 2 (70% to 89% aneurysm occlusion) or higher are found when the optimal projection is performed in the catheter cerebrovascularization tracked after coil treatment.
•4) Subjects who have heard and finally agreed to the explanation of this study

发起方